Keyphrases
Nasopharyngeal Carcinoma
100%
Antitumor Activity
100%
Polo-like Kinase Inhibitor
100%
Apoptosis
40%
Phosphorylation
20%
DNA Damage
20%
Tumor Growth
20%
Inhibitory Effect
20%
High Prevalence
20%
Cell Proliferation
20%
Cell Cycle Arrest
20%
Chemotherapy
20%
Inhibit Tumor
20%
Mitosis
20%
Cancer Cell Lines
20%
Intravenous Injection
20%
Drug Treatment
20%
Signaling Molecules
20%
Western Blotting
20%
Polo-like Kinase 1 (PLK1)
20%
Targeted Drugs
20%
Radiotherapy
20%
In Vivo Tumorigenicity
20%
Immunofluorescence
20%
WEE1
20%
Downstream Signaling
20%
Tumor Suppression
20%
Cdc25
20%
Survival Rate
20%
Chk2
20%
Time Cells
20%
Cell Fluorescence
20%
Antitumor Efficacy
20%
Treatment Modalities
20%
Annexin V Staining
20%
Southern Chinese
20%
Securin
20%
Fluorescence-activated Cell Sorting
20%
Sorting Analysis
20%
Tumor Chemoresistance
20%
Ther
20%
Medicine and Dentistry
Antineoplastic Activity
100%
Nasopharynx Carcinoma
100%
Polo Like Kinase Inhibitor
100%
In Vitro
40%
Programmed Cell Death
40%
Malignant Neoplasm
40%
Drug Therapy
20%
Tumor Progression
20%
Cell Line
20%
Cell Cycle Checkpoint
20%
Cell Cycle Arrest
20%
Cancer Cell Line
20%
Neoplasm
20%
Cell Cycle
20%
Cell Proliferation
20%
Antiinfective Agent
20%
Western Blot
20%
Prevalence
20%
Signaling Molecule
20%
Radiation Therapy
20%
Immunofluorescence
20%
Cancer Inhibition
20%
Drug Resistance
20%
Carcinogenicity
20%
Lipocortin 5
20%
DNA Damage
20%
Survival Rate
20%
Drug Delivery System
20%
Fluorescence Activated Cell Sorting
20%
Wee1
20%
Securin
20%
Treatment Modality
20%
Intravenous Injection
20%
Pharmacology, Toxicology and Pharmaceutical Science
Nasopharynx Carcinoma
100%
Antitumor Activity
100%
Polo Like Kinase Inhibitor
100%
Malignant Neoplasm
60%
Survival Rate
20%
Pharmacotherapy
20%
Antiinfective Agent
20%
Tumor Growth
20%
Western Blot
20%
Neoplasm
20%
Drug Delivery System
20%
Chemotherapy
20%
Cancer Inhibition
20%
Carcinogenicity
20%
Lipocortin 5
20%
Drug Resistance
20%
Prevalence
20%
Fluorescence Activated Cell Sorting
20%
Securin
20%